Información:
Error:
ID
34147
Descripción
A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01598285
Link
https://clinicaltrials.gov/show/NCT01598285
Palabras clave
Versiones (1)
- 14/1/19 14/1/19 -
Titular de derechos de autor
GSK group of companies
Subido en
14 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Cancer Invasive Nos NCT01598285
Eligibility Breast Cancer Invasive Nos NCT01598285
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer Invasive Nos NCT01598285
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
patients with breast cancer, at a disseminated stage
boolean
ID.2
Item
patients treated with bevacizumab in combination with weekly paclitaxel as first line chemotherapy and who have progressed
boolean
ID.3
Item
alive patients authorizing the extraction and analysis of their biological samples.
boolean
ID.4
Item
patients with a second neoplasia
boolean
ID.5
Item
deceased patients
boolean
ID.6
Item
patients who have not agreed to participate in the study
boolean
ID.7
Item
her2 positive patients
boolean
ID.8
Item
patients with cns metastases when first treated with bevacizumab in combination with paclitaxel
boolean
ID.9
Item
patients with local-regional recurrence only and
boolean
ID.10
Item
patients with status ned (resected metastases)
boolean